19.09.2014
- The decision by Swiss drugmaker Roche in August to buy US biotech company InterMune for $8.3 billion was "exceptional" and not a sign of more ambitious plans for major acquisitions...
25.08.2014
- Roche Holding has agreed to buy US biotech company InterMune for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector. The...
